Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,058.18
+37.343.66%
Post-market: 1,068.009.82+0.93%19:59 EST
Volume:4.89M
Turnover:5.14B
Market Cap:1.00T
PE:46.11
High:1,060.02
Open:1,056.00
Low:1,033.27
Close:1,020.84
52wk High:1,133.95
52wk Low:623.78
Shares:945.38M
Float Shares:945.00M
Volume Ratio:0.93
T/O Rate:0.52%
Dividend:6.00
Dividend Rate:0.57%
EPS(TTM):22.95
EPS(LYR):22.95
ROE:108.28%
ROA:17.60%
PB:42.04
PE(LYR):46.11

Loading ...

TrumpRx Is Here. Most People Won't Benefit. -- Barrons.com

Dow Jones
·
11 hours ago

Novo Nordisk shares rebound as FDA targets illegal drug copies

Reuters
·
Yesterday

FDA Vows Crackdown on Unapproved Weight-Loss Drug Copies, Boosting Shares of Novo Nordisk and Eli Lilly

Stock News
·
Yesterday

Premarket Movers | Novo-Nordisk Soars 8%, Eli Lilly up 3%, HIMS Dips 7%; Roblox Jumps 12%; Reddit up 7%; Stellantis Sinks 22%

Tiger Newspress
·
Yesterday

Alecta Pensionsforsakring trims Eli Lilly And Company stake

TIPRANKS
·
Yesterday

24H | Hims Shares Plunge over 9% After FDA Chief Threatens Action on "Illegal Copycat Drugs". Novo, Eli Lilly Jump over 2% Each

Reuters
·
Yesterday

White House Debuts Drug-Buying Site TrumpRx, With Roughly 40 Medications -- WSJ

Dow Jones
·
Yesterday

Eli Lilly & Co. Stock Slips 7.8%, Underperforms Peers

Dow Jones
·
Yesterday

CORRECTED-CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5)

Reuters
·
Yesterday

Eli Lilly Stock (LLY) Falls on News Hims & Hers Is Selling a $49 Weight-Loss Pill

TIPRANKS
·
Yesterday

Eli Lilly Beats Q4 Estimates But Shares Slide: Analyst Expects 'Clear Runway Into Next Decade'

Benzinga_recent_news
·
Feb 05

Stock Track | Eli Lilly Plummets 5.90% in Pre-market Amid Competitive Pressure from Hims & Hers and Novo Nordisk Guidance Disappointment

Stock Track
·
Feb 05

Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly

Reuters
·
Feb 05

Analysts Have Conflicting Sentiments on These Healthcare Companies: Wave Life Sciences (WVE) and Eli Lilly & Co (LLY)

TIPRANKS
·
Feb 05

Eli Lilly Shares Down 4.1% Premarket Following Reuters Report on Hims and Hers Health Launching Copy of Novo's Wegovy Pill at $49

THOMSON REUTERS
·
Feb 05

Eli Lilly Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Feb 05

Stock Track | Eli Lilly Plunges 5.07% in Pre-market as Weight-Loss Drug Sector Faces Pressure from Novo Nordisk Guidance Disappointment

Stock Track
·
Feb 05

Eli Lilly : Leerink Partners Raises Target Price to $1,296.00 From $1,234.00

THOMSON REUTERS
·
Feb 05

BUZZ-Street View: Eli Lilly's momentum is building despite pricing pressure

Reuters
·
Feb 05

Divergent Performance for Weight-Loss Drug Leaders: Eli Lilly Surges Over 10% on Strong Earnings

Deep News
·
Feb 05